Publication Products
| Chemical Structure | Cat. No. | Product Name | CAS No. |
|---|
 |
BCP03692 | Temozolomide | 85622-93-1 |
Temozolomide is a DNA-methylating agent. Temozolomide is an alkylating cytostatic drug.
|
|||
 |
BCP15615 | D-Luciferin New | 2591-17-5 |
D-Luciferin is a chemiluminescent substrate for luciferases. D-Luciferin produces fluorescence upon oxidation by luciferase in the presence of ATP.
|
|||
 |
BCP26351 | Fasudil hydrochloride | 105628-07-7 |
Fasudil Hydrochloride is a potent inhibitor of ROCK1, PKA, PKC, and MLCK with Kis of 0.33 μM, 1.0 μM, 9.3 μM and 55 μM, respectively.
|
|||
 |
BCP26821 | Fasudil | 103745-39-7 |
Fasudil, a Rho-kinase inhibitor, has been shown to reduce portal venous pressure in cirrhotic rats.
|
|||
 |
BCP01715 | Vismodegib New | 879085-55-9 |
Vismodegib is a more potent novel and specific synthetic oral hedgehog pathway inhibitor with an IC50 of 3 nM.
|
|||
 |
BCP01743 | BI 2536 | 755038-02-9 |
BI 2536 is Plk1 inhibitor with an IC50 of 0.83 nM.
|
|||
 |
BCP02337 | Plerixafor | 110078-46-1 |
Plerixafor (AMD3100) is a chemokine receptor antagonist for CXCR4 and CXCL12-mediated chemotaxis with IC50 of 44 nM and 5.7 nM, respectively.
|
|||
 |
BCP02829 | Bedaquiline New Discount | 843663-66-1 |
Bedaquiline, also known as TMC207 and R207910, is a diarylquinoline anti-tuberculosis drug.
|
|||
 |
BCP02555 | AZD4547 | 1035270-39-3 |
AZD4547 is an orally bioavailable inhibitor of the fibroblast growth factor receptor (FGFR) with potential antineoplastic activity.
|
|||
 |
BCP08392 | GSK 650394 | 890842-28-1 |
Serum- and glucocorticoid-regulated kinase 1 (SGK1) inhibitor (IC50 values are 62 and 103 nM for SGK1 and SGK2 respectively).
|
|||
 |
BCP07817 | Conivaptan | 210101-16-9 |
Conivaptan is a nonpeptide dual V1a/V2 AVP receptor antagonist.
|
|||
 |
BCP07838 | Delamanid New Hot | 681492-22-8 |
Delamanid, a newer mycobacterial cell wall synthesis inhibitor, inhibits the synthesisi of mucolic acids, cruciala component of the cell wall of the Mycobacterium tuberculosis complex.
|
|||
 |
BCP12422 | RGD (Arg-Gly-Asp) Peptides New | 99896-85-2 |
RGD Trifluoroacetate is a tripeptide that effectively triggers cell adhesion, addresses certain cell lines and elicits specific cell responses; binds to integrins. Sequence: Arg-Gly-Asp.
|
|||
 |
BCP20200 | MK-2206 New | 1032349-93-1 |
MK-2206 is a highly selective inhibitor of pan-Akt, namely, of all three Akt isoforms Akt1, Akt2, and Akt3.
|
|||
 |
BCP05341 | Deferasirox | 201530-41-8 |
Deferasirox is an iron chelator, also a cytochrome P450 3A4 inducer, Cytochrome P450 2C8 inhibitor, and Cytochrome P450 1A2 inhibitor.
|
|||
 |
BCP17382 | AS1842856 | 836620-48-5 |
AS1842856 is a cell-permeable Foxo1inhibitor that blocks the transcription activity of Foxo1 with IC50 of 33 nM.
|
|||
 |
BCP16068 | BMS-202 | 1675203-84-5 |
BMS-202 is an inhibitor of the PD-1/PD-L1 protein/protein interaction, mainly used for cancer treatment.
|
|||
 |
BCP16353 | 740Y-P New | 1236188-16-1 |
740 Y-P is a cell-permeable phosphopeptide activator of PI3K.
|
|||
 |
BCP27641 | Cabazitaxel Hot | 183133-96-2 |
A novel semi-synthetic taxane with antitumor activity used for the treatment of castration-resistant prostate cancer. A microtubule inhibitor.
|
|||
 |
BCP01767 | Sorafenib | 284461-73-0 |
Sorafenib is a multikinase inhibitor of Raf-1, B-Raf and VEGFR-2 with IC50 of 6 nM, 22 nM and 90 nM, respectively.
|
|||
